Evidence map›Paper›PMID 31302408›Full record

ArticleRedox biology2019

Short-term pharmacological activation of Nrf2 ameliorates vascular dysfunction in aged rats and in pathological human vasculature. A potential target for therapeutic intervention.

Javier Angulo, Mariam El Assar, Alejandro Sevilleja-Ortiz, Argentina Fernández, Alberto Sánchez-Ferrer, Javier Romero-Otero, Juan I Martínez-Salamanca, José M La Fuente, Leocadio Rodríguez-Mañas

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Javier AnguloServicio de Histología-Investigación, Unidad de Investigación Traslacional en Cardiología (IRYCIS-UFV), Hospital Ramón y Cajal, Madrid, Spain; Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
Mariam El AssarCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain; Fundación para la Investigación Biomédica del Hospital Universitario de Getafe, Getafe, Spain.
Alejandro Sevilleja-OrtizServicio de Histología-Investigación, Unidad de Investigación Traslacional en Cardiología (IRYCIS-UFV), Hospital Ramón y Cajal, Madrid, Spain.
Argentina FernándezServicio de Histología-Investigación, Unidad de Investigación Traslacional en Cardiología (IRYCIS-UFV), Hospital Ramón y Cajal, Madrid, Spain.
Alberto Sánchez-FerrerFundación para la Investigación Biomédica del Hospital Universitario de Getafe, Getafe, Spain.
Javier Romero-OteroServicio de Urología, Hospital Universitario Doce de Octubre, Madrid, Spain.
Juan I Martínez-SalamancaServicio de Urología, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
José M La FuenteServiço de Urologia, Hospital Santo Antonio, Porto, Portugal.
Leocadio Rodríguez-MañasCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain; Fundación para la Investigación Biomédica del Hospital Universitario de Getafe, Getafe, Spain; Servicio de Geriatría, Hospital Universitario de Getafe, Getafe, Spain. Electronic address: leocadio.rodriguez@salud.madrid.org.
Hospital Universitario de Getafe · ESInstituto de Salud Carlos III · ESHospital de Santo António · PTHospital Universitario 12 De Octubre · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Ramón y Cajal · ESInstituto Ramón y Cajal de Investigación Sanitaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress contributes to endothelial dysfunction, a key step in cardiovascular disease development. Ageing-related vascular dysfunction involves defective antioxidant response. Nuclear factor erythroid 2-like-2 (Nrf2), orchestrates cellular response to oxidative stress. We evaluated the impact of Nrf2-activation on endothelium-dependent and H

Indexed as

Age FactorsAnimalsBlood CirculationBlood VesselsDisease SusceptibilityEndotheliumFemaleHemodynamicsHumansHydrogen PeroxideMaleMiddle AgedNF-E2-Related Factor 2Nitric OxideOxidative StressRatsHydrogen PeroxideNF-E2-Related Factor 2Nitric OxideAgeingEndothelial dysfunctionErectile dysfunctionHuman vasculatureNrf2Oxidative stress

Identifiers

PMID31302408
PMCPMC6626891
OpenAlexW2954564453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.